WHITE MICHAEL ANTHONY 4
4 · IDEAYA Biosciences, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
WHITE MICHAEL ANTHONY
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-05-29$36.23/sh−27,649$1,001,588→ 851 total - Exercise/Conversion
Stock Option (right to buy)
2024-05-29−28,500→ 64,000 totalExercise: $12.86Exp: 2032-02-29→ Common Stock (28,500 underlying) - Exercise/Conversion
Common Stock
2024-05-29$12.86/sh+28,500$366,510→ 28,500 total - Sale
Common Stock
2024-05-29$36.78/sh−851$31,297→ 0 total
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on February 22, 2024.
- [F2]This transaction was executed in multiple trades in prices ranging from $35.68 to $36.655, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades in prices ranging from $36.68 to $36.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.